Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1385 (LINC01385)

Target
LINC01385
Molecular classification
Long non-coding RNA (lncRNA), Other (lincRNA: long intergenic non-coding RNA)
01

Overview

Long intergenic non-protein coding RNA 1385 (LINC01385) is a long non-coding RNA gene located on human chromosome 5. LincRNAs such as LINC01385 do not code for proteins but play regulatory roles in chromatin modification, transcription, and cellular signaling pathways. They are important in development and disease, especially cancer, where many lincRNAs are implicated in progression and metastasis. The biological roles and disease associations of LINC01385 itself remain largely uncharacterized, but the class as a whole is recognized as a promising area for biomarker development and therapeutic intervention. LINC01385 has an Ensembl Gene ID: ENSG00000251604 and Entrez Gene ID: 106144542. Its chromosomal location is on chromosome 5 (5:73,451,497-73,453,395). No specific drugs or clinical biomarkers have been documented interacting directly with LINC01385 as of the current genomics and GWAS databases. In summary: LINC01385 is a long intergenic non-coding RNA implicated as a functional member of lincRNA regulatory pathways, and is considered a potential therapeutic target largely on the basis of what is known for the class of lincRNAs in cancer biology, though its individual function and clinical relevance require further characterization.

Other names
TCONS_00009424
02

Mechanism of action

siRNA-mediated knockdown (for lincRNAs in general, not yet shown specifically for LINC01385); RNA-protein interaction inhibitors (potential strategy for lincRNAs in cancer)

03

Biological functions

Transcriptional regulationChromatin remodelingModulation of gene expression programs (may act as molecular scaffolds or guides for protein complexes)
04

Disease associations

Cancer (many lincRNAs are differentially expressed in cancer; implicated in diagnosis, prognosis, and as therapeutic targets)Other (potential involvement in other diseases via gene expression regulation, though specific disease associations for LINC01385 are not detailed in these sources)
05

Safety considerations

Off-target effects due to the ubiquitous nature and complex functions of lncRNAsChallenges in delivery and specificity of RNA-targeted therapeutics
06

Biomarkers

lincRNA expression patterns in cancer (lincRNAs in general may serve as biomarkers for cancer risk stratification and prognosis)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1385 (LINC01385).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1385 (LINC01385).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call